You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
The society for immunotherapy of cancer consensus statement on immunotherapy for the treatment of advanced renal cell carcinoma (RCC)
|
|---|---|
| Published in |
Journal for Immunotherapy of Cancer, December 2019
|
| DOI | 10.1186/s40425-019-0813-8 |
| Pubmed ID | |
| Authors |
Brian I. Rini, Dena Battle, Robert A. Figlin, Daniel J. George, Hans Hammers, Tom Hutson, Eric Jonasch, Richard W. Joseph, David F. McDermott, Robert J. Motzer, Sumanta K. Pal, Allan J. Pantuck, David I. Quinn, Virginia Seery, Martin H. Voss, Christopher G. Wood, Laura S. Wood, Michael B. Atkins |
X Demographics
The data shown below were collected from the profiles of 69 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 30 | 43% |
| Spain | 8 | 12% |
| Brazil | 4 | 6% |
| India | 2 | 3% |
| Canada | 2 | 3% |
| Mexico | 1 | 1% |
| Turkey | 1 | 1% |
| Argentina | 1 | 1% |
| Italy | 1 | 1% |
| Other | 3 | 4% |
| Unknown | 16 | 23% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 33 | 48% |
| Scientists | 16 | 23% |
| Practitioners (doctors, other healthcare professionals) | 16 | 23% |
| Science communicators (journalists, bloggers, editors) | 4 | 6% |
Mendeley readers
The data shown below were compiled from readership statistics for 176 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 176 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 22 | 13% |
| Other | 17 | 10% |
| Student > Ph. D. Student | 13 | 7% |
| Student > Doctoral Student | 12 | 7% |
| Student > Bachelor | 12 | 7% |
| Other | 34 | 19% |
| Unknown | 66 | 38% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 67 | 38% |
| Biochemistry, Genetics and Molecular Biology | 8 | 5% |
| Immunology and Microbiology | 4 | 2% |
| Agricultural and Biological Sciences | 4 | 2% |
| Pharmacology, Toxicology and Pharmaceutical Science | 4 | 2% |
| Other | 16 | 9% |
| Unknown | 73 | 41% |
Attention Score in Context
This research output has an Altmetric Attention Score of 170. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 January 2021.
All research outputs
#239,972
of 25,540,105 outputs
Outputs from Journal for Immunotherapy of Cancer
#43
of 3,454 outputs
Outputs of similar age
#5,740
of 479,087 outputs
Outputs of similar age from Journal for Immunotherapy of Cancer
#1
of 85 outputs
Altmetric has tracked 25,540,105 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,454 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.7. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 479,087 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 85 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.